Celladon Corporation

📍 United States👥 2 employees💰 Last funded Sep 2013
Biotechnology Research🌐 celladon.com
Website LinkedIn
Celladon (Nasdaq: CLDN) is a public biotechnology company founded with the goal of developing molecular therapies for cardiovascular diseases. Breakthroughs in the basic understanding of the cardiovascular networks combined with powerful new technologies have provided the foundation for new, rational, and technologically sophisticated approaches to cardiovascular treatments. Our first product candidate is designed to target the key enzyme deficiency in advanced heart failure which regulates calcium cycling and contractility in heart muscle cells.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Celladon Corporation?
Celladon Corporation has 2 investors on record on gritt.io.
When did Celladon Corporation last raise funding?
The most recent investment in Celladon Corporation recorded on gritt.io was in September 2013.
What industry is Celladon Corporation in?
Celladon Corporation operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Celladon Corporation based?
Celladon Corporation is headquartered in United States.